SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 150.49 |
| Enterprise Value ($M) | 112.59 |
| Book Value ($M) | 95.51 |
| Book Value / Share | 0.72 |
| Price / Book | 1.58 |
| NCAV ($M) | 89.64 |
| NCAV / Share | 0.68 |
| Price / NCAV | 1.68 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.07 |
| Return on Assets (ROA) | -0.62 |
| Return on Equity (ROE) | -0.73 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.90 |
| Current Ratio | 9.90 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 102.60 |
| Assets | 108.47 |
| Liabilities | 12.96 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Redmile Group, LLC | 9.90 | 268.89 | |
| 13G/A | Perceptive Advisors Llc | 4.50 | 174.77 | |
| 13G | Orbimed Advisors Llc | 9.90 | ||
| 13G/A | Vanguard Group Inc | 2.22 | -7.09 | |
| 13G/A | Fmr Llc | 0.40 | -90.82 | |
| 13G | Medicxi IV LP | 16.90 | ||
| 13G | Biotechnology Value Fund L P | 8.70 | ||
| 13G | TCG Crossover GP II, LLC | 9.99 | ||
| 13G | Foresite Capital Fund VI LP | 9.30 | ||
| 13D/A | Column Group Ii, Lp | 4.90 | -63.76 | |
| 13G | Deep Track Capital, LP | 9.87 | ||
| 13G/A | Price T Rowe Associates Inc /md/ | 0.50 | -94.85 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 82,641 | 304,017 | 27.18 | |
| 81,484 | 248,065 | 32.85 | |
| 118,545 | 678,843 | 17.46 | |
| 131,625 | 457,249 | 28.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PTGX – Protagonist Therapeutics, Inc. | QTTB – Q32 Bio Inc. |
| RANI – Rani Therapeutics Holdings, Inc. | RCKT – Rocket Pharmaceuticals, Inc. |
| RLAY – Relay Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io